Skip to main content
GLPG
NASDAQ Life Sciences

Bank of America Discloses Over 5% Stake in Galapagos NV

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$33.92
Mkt Cap
$2.186B
52W Low
$22.591
52W High
$37.78
52W Position info
50% above low
Off High info
10% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

GLPG sits 50% above its 52-week low of $22.591.

Summary

Bank of America Corporation has reported crossing the 5% ownership threshold in Galapagos NV, acquiring a significant stake through direct voting rights and equivalent financial instruments.


Key Events · Ownership and Investor Activity · GLPG

  • Bank of America Crosses 5% Ownership

    Bank of America Corporation disclosed that it crossed the 5% ownership threshold in Galapagos NV on February 9, 2026, now holding 5.34% of voting rights.

  • Substantial Institutional Investment

    The reported stake, comprising direct voting rights and equivalent financial instruments, represents an approximate $119 million investment by the financial institution.

  • Follows Strategic Shift

    This significant institutional stake comes after Galapagos' January 5, 2026 announcement to wind down its cell therapy activities, potentially signaling confidence in the company's refocused strategy.


Analysis · GLPG · Life Sciences

This filing reveals that Bank of America Corporation, a major institutional investor, has accumulated a substantial stake in Galapagos NV, now holding 5.34% of the company's voting rights and equivalent financial instruments. This acquisition, valued at approximately $119 million, represents a significant institutional investment and could be interpreted as a vote of confidence in Galapagos' strategic direction, particularly following the company's recent decision to wind down its cell therapy activities. Such a large stake by a prominent financial entity may attract further investor attention.

At the time of this filing, GLPG was trading at $33.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $22.59 to $37.78. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GLPG - Latest Insights

GLPG
May 06, 2026, 5:19 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $28.81
Real-time Price: $28.49 info
Change: -$0.320 (-1%) info
Market Cap: $1.821B info
GLPG
May 06, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.81
Real-time Price: $28.49 info
Change: -$0.320 (-1%) info
Market Cap: $1.821B info
GLPG
Apr 29, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $28.42
Real-time Price: $28.49 info
Change: +$0.070 (+0.25%) info
Market Cap: $1.821B info
GLPG
Mar 31, 2026, 1:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $28.84
Real-time Price: $28.49 info
Change: -$0.350 (-1%) info
Market Cap: $1.821B info
GLPG
Mar 30, 2026, 9:41 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $29.46
Real-time Price: $28.49 info
Change: -$0.970 (-3%) info
Market Cap: $1.821B info